Global Cannabis Pharmaceuticals Market

Cannabis Pharmaceuticals Market Size, Share, Growth Analysis, By Product (Sativex, Cesamet), By Distribution Channel (Online Pharmacies, Hospitals), By Region - Industry Forecast 2026-2033

Report ID: SQMIG35I2243 | Region: Global | Published Date: May, 2025
Pages: 157 |Tables: 35 |Figures: 74

To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt

    • FAQs

    Global Cannabis Pharmaceuticals Market size was valued at USD 3.93 Billion in 2024 and is poised to grow from USD 6.17 Billion in 2025 to USD 228.93 Billion by 2033, growing at a CAGR of 57.1% during the forecast period (2026–2033).

    Several companies in the market are captured in fierce competition as they strive to expand the range of medical conditions that can be treated with cannabis-derived compounds by putting in significant investments in research and development to discover new cannabinoid-based pharmaceuticals. These efforts include the conduction of clinical trials to research and establish the safety and efficacy of cannabis products. In order to speed up market penetration and product development, these companies are employing strategic collaborations. Companies were bringing in a diverse range of offerings to their existing product portfolios by developing various forms of cannabis-based medicines, including transdermal patches, inhalers, oral medications, and more, thus allowing them to cater to a wider range of patient needs and preferences. 'Jazz Pharmaceuticals plc (Ireland) ', 'Insys Therapeutics, Inc. (USA) ', 'Corbus Pharmaceuticals Holdings, Inc. (USA) ', 'Botanix Pharmaceuticals Ltd (Australia) ', 'Canopy Growth Corporation (Canada) ', 'Tilray Brands, Inc. (USA) ', 'Aurora Cannabis Inc. (Canada) ', 'Almac Group (UK) ', 'Catalent, Inc. (USA) ', 'Cara Therapeutics, Inc. (USA) ', 'Axim Biotechnologies, Inc. (USA) ', 'MediPharm Labs Corp. (Canada) ', 'ECS Botanics (Australia) ', 'Neurotech International (Australia) ', 'Emyria Limited (Australia)'

    A prominent driver in the cannabis pharmaceutical market is the growing rate of legalization of medical cannabis in various countries and states. As more areas accept and permit the use of cannabis for medicinal purposes, it strengthens the market's potential.

    Diverse Product Formats: Consumer choice and accessibility of cannabis products is increasing with the introduction of an expanding range of product formats, including edibles, oils, and capsules.

    North America, led by countries like the United States and Canada, has been one of the most prominent regions in the global cannabis pharmaceutical market. In recent years, North America has seen a boom in both medical and recreational cannabis legalization, further stimulating market growth. Driven by the increasing acceptance of cannabis as a treatment option and the availability of multiple cannabis-derived pharmaceuticals, the United States, in particular, has seen a tremendous development in the use of cannabis for medicinal purposes. Moreover, North America's rich ecosystem of research and development and the presence of major cannabis pharmaceutical companies greatly contribute to retaining its position in the market.

    Related Reports

    Cannabis Market
    Buy Now GET FREE SAMPLE
    Medical Cannabis Market
    Buy Now GET FREE SAMPLE
    Cannabis Tech Market
    Buy Now GET FREE SAMPLE
    Pharmaceuticals Market
    Buy Now GET FREE SAMPLE
    Legal Cannabis Market
    Buy Now GET FREE SAMPLE
    Cannabis Testing Market
    Buy Now GET FREE SAMPLE
    U.S. Cannabinoids Market
    Buy Now GET FREE SAMPLE
    North America Legal Cannabis Market
    Buy Now GET FREE SAMPLE

    Feedback From Our Clients

    Global Cannabis Pharmaceuticals Market

    Report ID: SQMIG35I2243

    $5,300
    BUY NOW